SCAD Long-term Management — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — SCAD recurrence affects approximately 10-30% of patients over 10 years; lifelong cardiovascular follow-up and avoidance of extreme physical exertion and hormonal triggers are recommended
SCAD has a significant long-term recurrence rate of approximately 10-30% over 5-10 years, typically affecting a different coronary artery than the index event. The 2023 ESC ACS Guidelines recommend: (1) conservative management as default for SCAD (PCI/CABG only for ongoing ischaemia or haemodynamic instability); (2) lifelong follow-up with CCTA or invasive angiography if symptoms recur; (3) screening for associated conditions (fibromuscular dysplasia in 50-70% of cases, other arteriopathies); (4) avoidance of extreme physical exertion (e.g. competitive sport, heavy isometric exercise) and hormonal triggers (pregnancy carries high recurrence risk). Dual antiplatelet therapy is not clearly beneficial long-term.
Reference: ESC (2023): Guidelines for the Management of Acute Coronary Syndromes; EuroPCR SCAD Consensus